HTT and Huntington disease: PolyQ-expanded Ataxin-2 abundance in biofluids would be an obvious candidate biomarker for SCA2, similar to what was described for huntingtin or Ataxin-3 proteins in Huntington ́s disease (HD) or SCA3, respectively40–42.